2-Arylpropionic Acid Pyrazolamides as Cannabinoid CB2 Receptor Inverse Agonists Endowed with Anti-Inflammatory Properties
Among the most recent proposals regarding the mechanism of action of dipyrone, the modulation of cannabinoid receptors CB<sub>1</sub> and CB<sub>2</sub> appears to be a promising hypothesis. In this context, the present work describes a series of five novel pyrazolamides (<...
Main Authors: | Daniela R. de Oliveira, Rodolfo C. Maia, Patrícia R. de Carvalho França, Patrícia D. Fernandes, Gisele Barbosa, Lídia M. Lima, Carlos A. Manssour Fraga |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/15/12/1519 |
Similar Items
-
Characterization of Subtype Selective Cannabinoid CB<sub>2</sub> Receptor Agonists as Potential Anti-Inflammatory Agents
by: Yaliang Tang, et al.
Published: (2021-04-01) -
Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB2 receptor
by: Monica Patel, et al.
Published: (2023-12-01) -
Tricyclic Pyrazole-Based Compounds as Useful Scaffolds for Cannabinoid CB<sub>1</sub>/CB<sub>2</sub> Receptor Interaction
by: Battistina Asproni, et al.
Published: (2021-04-01) -
Novel Cannabinoid Receptor 2 (CB2) Low Lipophilicity Agonists Produce Distinct cAMP and Arrestin Signalling Kinetics without Bias
by: Raahul Sharma, et al.
Published: (2023-03-01) -
Requiem for Rimonabant: Therapeutic Potential for Cannabinoid CB<sub>1</sub> Receptor Antagonists after the Fall
by: Taryn Bosquez-Berger, et al.
Published: (2023-08-01)